Article Details
Retrieved on: 2024-05-07 18:18:30
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the potential of low-dose Naltrexone to treat long COVID and ME/CFS by restoring immune cell ion channel function, with upcoming clinical trials to test its effectiveness, linking neuroscience to ion channels and fatigue-related conditions.
Article found on: neurosciencenews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here